Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Erythropoiesis Stimulating Agent Pharmacodynamics”

7 trials

Showing 7 of 7 results

Testing effectiveness (Phase 2)Study completedNCT00228436
What this trial is testing

Safety, PD & PK of Multiple Doses of Peginesatide for Anemia in Chronic Kidney Disease Patients

Who this might be right for
AnemiaChronic Kidney DiseaseChronic Renal Failure
Affymax 139
Testing effectiveness (Phase 2)Study completedNCT00434330
What this trial is testing

Peginesatide for Maintenance Treatment of Anemia in Participants on Hemodialysis

Who this might be right for
AnemiaChronic Kidney DiseaseChronic Renal Failure
Affymax 91
Testing effectiveness (Phase 2)Study completedNCT00228449
What this trial is testing

Peginesatide for Anemia in Chronic Hemodialysis Patients

Who this might be right for
AnemiaChronic Kidney DiseaseChronic Renal Failure
Affymax 165
Testing effectiveness (Phase 2)Study completedNCT00272662
What this trial is testing

Study of Subcutaneously Administered Peginesatide in Anemic Cancer Patients Receiving Chemotherapy

Who this might be right for
Chemotherapy Induced AnemiaCancer
Affymax 60
Not applicableStudy completedNCT01666301
What this trial is testing

ESAs, Reticulocyte Dynamic and Hemoglobin Variability

Who this might be right for
Erythropoiesis Stimulating Agent Pharmacodynamics
Ospedale Regionale di Locarno 31
Early research (Phase 1)Study completedNCT03992066
What this trial is testing

Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Vadadustat in Hemodialysis Subjects With Anemia Associated With Chronic Kidney Disease

Who this might be right for
Anemia Associated With Chronic Kidney Disease
Akebia Therapeutics 46
Testing effectiveness (Phase 2)Ended earlyNCT00109291
What this trial is testing

Safety of Single Doses of Peginesatide in Patients With Chronic Kidney Disease

Who this might be right for
AnemiaChronic Kidney DiseaseChronic Renal Failure
Affymax 17

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation